交易 Grifols, S.A. - GRLS CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
价差 | 0.09 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.022079% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | -0.000143% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | EUR | ||||||||
保证金 | 5% | ||||||||
上市交易所 | Spain | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Grifols SA ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Dec 8, 2023 | 14.14 | 0.40 | 2.91% | 13.74 | 14.18 | 13.64 |
Dec 7, 2023 | 13.70 | 0.06 | 0.44% | 13.64 | 14.06 | 13.48 |
Dec 6, 2023 | 13.86 | 0.75 | 5.72% | 13.11 | 13.88 | 13.11 |
Dec 5, 2023 | 13.22 | 0.06 | 0.46% | 13.16 | 13.24 | 13.03 |
Dec 4, 2023 | 13.18 | 0.25 | 1.93% | 12.93 | 13.19 | 12.89 |
Dec 1, 2023 | 12.87 | -0.08 | -0.62% | 12.95 | 12.98 | 12.70 |
Nov 30, 2023 | 12.94 | 0.26 | 2.05% | 12.68 | 13.01 | 12.63 |
Nov 29, 2023 | 12.63 | -0.22 | -1.71% | 12.85 | 12.95 | 12.59 |
Nov 28, 2023 | 12.81 | -0.39 | -2.95% | 13.20 | 13.70 | 12.74 |
Nov 27, 2023 | 13.09 | 0.11 | 0.85% | 12.98 | 13.34 | 12.98 |
Nov 24, 2023 | 13.08 | 0.41 | 3.24% | 12.67 | 13.10 | 12.67 |
Nov 23, 2023 | 12.84 | 0.10 | 0.78% | 12.74 | 12.84 | 12.59 |
Nov 22, 2023 | 12.70 | 0.00 | 0.00% | 12.70 | 12.80 | 12.63 |
Nov 21, 2023 | 12.71 | -0.02 | -0.16% | 12.73 | 12.85 | 12.63 |
Nov 20, 2023 | 12.71 | 0.03 | 0.24% | 12.68 | 12.73 | 12.56 |
Nov 17, 2023 | 12.62 | -0.10 | -0.79% | 12.72 | 12.87 | 12.60 |
Nov 16, 2023 | 12.66 | -0.03 | -0.24% | 12.69 | 12.81 | 12.57 |
Nov 15, 2023 | 12.68 | 0.40 | 3.26% | 12.28 | 12.78 | 12.25 |
Nov 14, 2023 | 12.22 | 0.47 | 4.00% | 11.75 | 12.32 | 11.67 |
Nov 13, 2023 | 11.61 | 0.05 | 0.43% | 11.56 | 11.71 | 11.41 |
Grifols, S.A. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
沒有活動安排 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 6063.97 | 4933.12 | 5340.04 | 5098.69 | 4486.72 |
收入 | 6063.97 | 4933.12 | 5340.04 | 5098.69 | 4486.72 |
收入成本,共計 | 3832.44 | 2970.52 | 3084.87 | 2757.46 | 2437.16 |
毛利 | 2231.53 | 1962.6 | 2255.17 | 2341.23 | 2049.56 |
總營業費用 | 5258.29 | 4338.05 | 4343.91 | 4004.99 | 3462.32 |
銷售/一般/行政費用,總計 | 1102.37 | 968.728 | 895.207 | 855.918 | 752.532 |
研究與開發 | 316.845 | 299.57 | 261.402 | 253.547 | 220.825 |
Depreciation / Amortization | 132.352 | 148.091 | 123.223 | 109.374 | 82.079 |
營業收入 | 805.68 | 595.064 | 996.132 | 1093.7 | 1024.4 |
利息收入(費用),非經營淨值 | -310.528 | -200.43 | -90.785 | -258.012 | -279.451 |
其他,淨值 | -133.895 | -44.181 | -26.718 | -18.584 | -19.111 |
稅前淨收入 | 361.257 | 350.453 | 878.629 | 817.103 | 725.842 |
稅後淨收入 | 271.146 | 265.327 | 747.89 | 648.644 | 594.406 |
少數股東權益 | -62.867 | -76.601 | -90.444 | -23.498 | 2.236 |
未計算非常項目前的淨收益 | 208.279 | 188.726 | 657.446 | 625.146 | 596.642 |
淨收入 | 208.279 | 188.726 | 618.546 | 625.146 | 596.642 |
普通股股東可獲收益 (不含非經常性項目) | 208.279 | 188.726 | 657.446 | 625.146 | 596.642 |
普通股股東可獲收益 (含非經常性項目) | 208.279 | 188.726 | 618.546 | 625.146 | 596.642 |
攤薄淨收入 | 208.279 | 188.726 | 618.546 | 625.146 | 596.642 |
攤薄後加權平均股 | 679.805 | 681.557 | 685.516 | 686.974 | 685.795 |
扣除特別項目的每股攤薄盈利 | 0.30638 | 0.2769 | 0.95905 | 0.91 | 0.87 |
Dividends per Share - Common Stock Primary Issue | 0.36435 | 0.36159 | 0.34514 | ||
每股正常攤薄盈利 | 0.48985 | 1.0494 | 1.01307 | 0.95353 | 0.83384 |
異常費用(收入) | 0 | 0 | 37.666 | -30.28 | |
利息費用(收入) - 淨運營 | -103.478 | -32.555 | -20.799 | -8.972 | |
非常規項目總計 | -38.9 | ||||
Other Operating Expenses, Total | -22.235 | -16.302 |
Jun 2023 | Mar 2023 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
總收入 | 1663.46 | 1561.49 | 1542.9 | 1267.19 | 4933.12 |
收入 | 1663.46 | 1561.49 | 1542.9 | 1267.19 | 4933.12 |
收入成本,共計 | 1044.99 | 1007.05 | 964.949 | 772.592 | 2970.52 |
毛利 | 618.467 | 554.439 | 577.95 | 494.601 | 1962.6 |
總營業費用 | 1420.06 | 1510.86 | 1277.53 | 1105.22 | 4338.05 |
銷售/一般/行政費用,總計 | 271.613 | 413.659 | 281.54 | 235.377 | 1061.51 |
研究與開發 | 78.662 | 104.657 | 75.841 | 67.282 | 354.881 |
利息費用(收入) - 淨運營 | -13.022 | -14.506 | -80.096 | 0.637 | -32.555 |
Other Operating Expenses, Total | 0 | 0 | -0.926 | -3.582 | -16.302 |
營業收入 | 243.396 | 50.629 | 265.373 | 161.973 | 595.064 |
利息收入(費用),非經營淨值 | -99.872 | -134.803 | -110.005 | -90.04 | -200.43 |
稅前淨收入 | 103.219 | -84.174 | 145.722 | 82.165 | 350.453 |
稅後淨收入 | 89.871 | -80.945 | 114.918 | 61.694 | 265.327 |
少數股東權益 | -37.826 | -27.321 | -24.578 | -8.385 | -76.601 |
未計算非常項目前的淨收益 | 52.045 | -108.266 | 90.34 | 53.309 | 188.726 |
非常規項目總計 | |||||
淨收入 | 52.045 | -108.266 | 90.34 | 53.309 | 188.726 |
普通股股東可獲收益 (不含非經常性項目) | 52.044 | -108.266 | 90.34 | 53.309 | 188.726 |
普通股股東可獲收益 (含非經常性項目) | 52.044 | -108.266 | 90.34 | 53.309 | 188.726 |
攤薄淨收入 | 52.044 | -108.266 | 90.34 | 53.309 | 188.726 |
攤薄後加權平均股 | 650.55 | 678.411 | 694.923 | 689.483 | 681.557 |
扣除特別項目的每股攤薄盈利 | 0.08 | -0.15959 | 0.13 | 0.07732 | 0.2769 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | 0.08 | -0.15959 | 0.13 | 0.07732 | 0.49178 |
其他,淨值 | -40.305 | -9.646 | 10.232 | -44.181 | |
異常費用(收入) | 0 | ||||
Depreciation / Amortization | 37.818 | 36.218 | 32.914 | ||
Total Adjustments to Net Income | -0.001 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 4653.59 | 5510.28 | 3164.95 | 5362.18 | 3483.25 |
現金和短期投資 | 591.642 | 2685.2 | 590.765 | 2470.91 | 1087.76 |
现金 | 547.974 | 655.493 | 444.772 | 741.919 | 592.178 |
現金等價物 | 0.005 | 0 | 134.875 | 0.063 | 441.614 |
短期投資 | 43.663 | 2029.71 | 11.118 | 1728.93 | 53.965 |
應收賬款總額,淨額 | 754.772 | 495.437 | 504.105 | 469.711 | 368.364 |
應收賬款 - 貿易,淨額 | 643.842 | 434.136 | 383.233 | 369.797 | 269.167 |
總庫存 | 3201.36 | 2259.35 | 2002.28 | 2342.59 | 1949.36 |
預付的費用 | 19.033 | 6.21 | 16.053 | 20.864 | 35.426 |
其他流動資産,總計 | 86.783 | 64.079 | 51.75 | 58.111 | 42.344 |
總資産 | 21534 | 19233.8 | 15274.8 | 15542.6 | 12477 |
物業/廠房/設備,總計 - 淨額 | 4168.49 | 3343.15 | 3002.8 | 2863.4 | 1951.98 |
物業/廠房/設備,總計 - 總額 | 6251.94 | 5127.29 | 4472.6 | 4207.52 | 3056.66 |
累計折舊,總計 | -2083.45 | -1784.13 | -1469.8 | -1344.11 | -1104.67 |
商譽,淨額 | 7011.91 | 6228.9 | 5332.27 | 5507.06 | 5209.23 |
無形資産,淨額 | 2949.15 | 1636.95 | 1557.65 | 1433.53 | 1385.54 |
長期投資 | 2575.92 | 2362.04 | 2067.18 | 253.403 | 334.506 |
其他長期資産,總計 | 174.923 | 152.507 | 149.921 | 123.024 | 112.539 |
流動負債總額 | 1955.85 | 3474.31 | 1335.14 | 1366.56 | 1257.32 |
應付賬款 | 731.918 | 628.992 | 601.618 | 581.882 | 561.883 |
預提費用 | 199.584 | 175.71 | 121.972 | 175.079 | 153.16 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 681.273 | 2484.18 | 373.25 | 319.544 | 261.12 |
其他流動負債,總計 | 343.072 | 185.43 | 238.298 | 290.053 | 281.158 |
負債總額 | 15404 | 13710.2 | 10166.4 | 10720.5 | 8251.49 |
長期債務總額 | 9068.85 | 7179.48 | 6885.04 | 6089.8 | 6020.51 |
長期債務 | 8154.26 | 6354.33 | 6194.19 | 5393.52 | 6010.97 |
資本租賃義務 | 914.588 | 825.157 | 690.857 | 696.285 | 9.537 |
遞延所得稅 | 1034.82 | 633.984 | 556.813 | 463.827 | 404.398 |
少數股權 | 2327.61 | 1793.49 | 1611.66 | 2023.65 | 471.05 |
其他負債,總計 | 1016.91 | 628.958 | -222.273 | 776.656 | 98.215 |
總權益 | 6129.94 | 5523.61 | 5108.39 | 4822.12 | 4225.55 |
普通股 | 119.604 | 119.604 | 119.604 | 119.604 | 119.604 |
額外實收資本 | 910.728 | 910.728 | 910.728 | 910.728 | 910.728 |
留存收益(累計赤字) | 4534.71 | 4322.11 | 4395.48 | 3497.92 | 2901.83 |
Treasury Stock - Common | -162.22 | -164.189 | -43.734 | -49.584 | -55.441 |
Unrealized Gain (Loss) | 0 | ||||
其他權益,總計 | 727.111 | 335.352 | -273.684 | 343.454 | 348.837 |
總負債和股東權益 | 21534 | 19233.8 | 15274.8 | 15542.6 | 12477 |
已發行普通股總數 | 678.411 | 678.54 | 684.543 | 680.321 | 679.918 |
Sep 2023 | Jun 2023 | Mar 2023 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 5015.37 | 4804.77 | 4708.89 | 4432.77 | |
現金和短期投資 | 543.636 | 557.34 | 463.985 | 561.593 | |
現金等價物 | 484.226 | 523.352 | 425.655 | 525.094 | |
短期投資 | 59.41 | 33.988 | 38.33 | 36.499 | |
應收賬款總額,淨額 | 908.03 | 865.708 | 884.234 | 772.932 | |
應收賬款 - 貿易,淨額 | 908.03 | 721.208 | 884.234 | 637.226 | |
總庫存 | 3486.68 | 3317.45 | 3277.05 | 2933.64 | |
其他流動資産,總計 | 77.019 | 64.276 | 83.616 | 164.611 | |
總資産 | 22064.5 | 21432.7 | 21350.8 | 21039.1 | |
物業/廠房/設備,總計 - 淨額 | 3278.65 | 4093.39 | 3220.43 | 4227.93 | |
無形資産,淨額 | 10876.2 | 2880.25 | 10646.8 | 1736.91 | |
長期投資 | 2597.29 | 2536.04 | 2576.89 | 2589.06 | |
其他長期資産,總計 | 296.952 | 219.468 | 197.837 | 204.483 | |
流動負債總額 | 2025.06 | 1876.98 | 2041.28 | 1656.33 | |
應付票據/短期債務 | 0 | 0 | 0 | 0 | |
長期債務的當前部分/資本租賃 | 757.246 | 655.165 | 761.319 | 401.283 | |
其他流動負債,總計 | 1267.81 | 512.849 | 1279.96 | 553.889 | |
負債總額 | 15937.4 | 15570.9 | 15498 | 14709.2 | |
長期債務總額 | 10299.4 | 9372.97 | 9998.56 | 9155 | |
長期債務 | 10299.4 | 8482.51 | 9998.56 | 8146.33 | |
少數股權 | 2441.61 | 2361.75 | 2322.37 | 2089.55 | |
其他負債,總計 | 1171.31 | 956.308 | 1135.78 | 1107.71 | |
總權益 | 6127.08 | 5861.82 | 5852.83 | 6329.83 | |
普通股 | 119.604 | 119.604 | 119.604 | 119.604 | |
額外實收資本 | 910.728 | 910.728 | 910.728 | 910.728 | |
留存收益(累計赤字) | 4532.18 | 4473.02 | 4426.39 | 4464.28 | |
Treasury Stock - Common | -158.692 | -158.692 | -162.22 | -158.761 | |
其他權益,總計 | 723.26 | 517.162 | 558.334 | 993.987 | |
總負債和股東權益 | 22064.5 | 21432.7 | 21350.8 | 21039.1 | |
已發行普通股總數 | 678.665 | 678.665 | 678.411 | 678.911 | |
物業/廠房/設備,總計 - 總額 | 6256.01 | 6226.29 | |||
累計折舊,總計 | -2162.61 | -1998.36 | |||
商譽,淨額 | 6898.82 | 7847.91 | |||
應付賬款 | 708.97 | 701.158 | |||
資本租賃義務 | 890.458 | 1008.67 | |||
遞延所得稅 | 1002.92 | 700.648 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 361.257 | 350.453 | 878.629 | 817.103 | 725.842 |
经营活动产生的现金 | -10.867 | 596.975 | 1110.34 | 568.933 | 737.428 |
经营活动产生的现金 | 407.864 | 359.767 | 321.533 | 302.455 | 228.609 |
非现金物品 | 372.572 | 214.726 | 88.233 | 267.505 | 225.769 |
Cash Taxes Paid | 196.436 | 30.595 | 131.51 | 107.797 | 111.585 |
已付现金利息 | 350.387 | 155.12 | 155.788 | 236.179 | 225.146 |
营运资金的变化 | -1152.56 | -327.971 | -178.059 | -818.13 | -442.792 |
投资活动产生的现金 | -1978.82 | -854.149 | -858.115 | -548.789 | -781.867 |
资本支出 | -375.56 | -315.088 | -362.56 | -412.305 | -307.722 |
其他投资现金流量项目,总计 | -1603.26 | -539.061 | -495.555 | -136.484 | -474.145 |
融资活动产生的现金 | -173.493 | 2297.68 | -354.401 | -332.356 | 152.503 |
融资现金流项目 | 7.93 | -64.052 | 2.202 | -86.101 | 393.926 |
Total Cash Dividends Paid | -0.592 | -258.946 | -113.23 | -238.74 | -278.841 |
股票的发行(报废),净额 | -3.459 | -125.703 | 0 | ||
债务的发行(退还),净额 | -177.372 | 2746.38 | -243.373 | -7.515 | 37.418 |
外汇效应 | 35.551 | 55.459 | -60.155 | 20.402 | 39.207 |
现金净变化 | -2127.63 | 2095.96 | -162.335 | -291.81 | 147.271 |
Mar 2023 | Jun 2022 | Mar 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -108.266 | 227.887 | 350.453 | 378.235 | |
Cash From Operating Activities | -61.462 | 26.442 | 596.975 | 339.302 | |
Cash From Operating Activities | 119.813 | 187.208 | 359.767 | 166.754 | |
Non-Cash Items | 92.589 | 132.125 | 214.726 | 56.525 | |
Changes in Working Capital | -165.598 | -520.778 | -327.971 | -262.212 | |
Cash From Investing Activities | -83.037 | -1797.05 | -854.149 | -623.362 | |
Capital Expenditures | -63.531 | -143.041 | -315.088 | -132.621 | |
Other Investing Cash Flow Items, Total | -19.506 | -1654.01 | -539.061 | -490.741 | |
Cash From Financing Activities | 29.008 | -432.688 | 2297.68 | 85.11 | |
Financing Cash Flow Items | 7.124 | 5.415 | -64.052 | 2.756 | |
Issuance (Retirement) of Debt, Net | -438.103 | 2746.38 | 467.002 | ||
Foreign Exchange Effects | -6.833 | 52.781 | 55.459 | 17.167 | |
Net Change in Cash | -122.324 | -2150.52 | 2095.96 | -181.783 | |
Total Cash Dividends Paid | 0 | -258.946 | -258.945 | ||
Issuance (Retirement) of Stock, Net | 21.884 | 0 | -125.703 | -125.703 | |
Cash Taxes Paid | 125.949 | 30.595 | 9.679 | ||
Cash Interest Paid | 123.787 | 155.12 | 71.286 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Roura Carreras (Nuria) | Individual Investor | 6.1541 | 26224374 | 0 | 2022-02-21 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.7792 | 16104193 | -340181 | 2023-10-26 | LOW |
Capital Research Global Investors | Investment Advisor | 3.033 | 12924438 | -11191375 | 2022-05-19 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.3199 | 9885627 | 2544944 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.155 | 9182978 | 121140 | 2023-09-30 | LOW |
BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 1.3682 | 5830475 | -271372 | 2023-09-30 | LOW |
Caixabank Asset Management SGIIC, S.A.U. | Investment Advisor | 1.2509 | 5330584 | 3376723 | 2023-06-30 | MED |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.8217 | 3501348 | 8625 | 2023-09-30 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.6527 | 2781235 | 3195 | 2023-09-30 | LOW |
Devon Equity Management Ltd. | Investment Advisor | 0.6421 | 2736000 | 0 | 2023-07-31 | LOW |
LGT Capital Partners Ltd. | Investment Advisor/Hedge Fund | 0.6162 | 2625854 | 0 | 2022-11-30 | LOW |
AG2R La Mondiale Gestion d'Actifs SA | Investment Advisor | 0.588 | 2505671 | -131908 | 2023-05-31 | LOW |
Bestinver Gestión S.A., S.G.I.I.C. | Investment Advisor/Hedge Fund | 0.5202 | 2216673 | -102829 | 2023-06-30 | MED |
Credit Suisse Funds AG | Investment Advisor/Hedge Fund | 0.4916 | 2094759 | -6890 | 2023-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4523 | 1927491 | 808 | 2023-09-30 | LOW |
BNP Paribas Asset Management Belgium S.A. | Investment Advisor | 0.4256 | 1813569 | 0 | 2023-09-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3949 | 1682793 | 95 | 2023-09-30 | LOW |
Addenda Capital, Inc. | Investment Advisor/Hedge Fund | 0.3506 | 1493991 | 0 | 2023-08-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 0.3492 | 1487884 | -33190 | 2023-09-30 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 0.287 | 1222955 | 137684 | 2023-03-31 | MED |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Grifols Company profile
关于 Grifols S.A.
Grifols SA是一家总部设在西班牙的全球专业制药公司,开发、生产和销售以血浆衍生蛋白为基础的广泛的生物药品。 该公司将其业务分为五个部门。 生物科学、诊断、医院、生物用品和其他。 生物科学包括用于治疗的血浆衍生物的生产活动以及终端产品的销售和分销。 诊断部专注于研究、开发、制造和销售体外诊断产品,如用于实验室的分析仪器、试剂和软件等。 医院为医院、诊所和专业中心提供制造药品的技术和服务,以及生理盐水、肠道营养液和介入治疗的医疗器械。 生物用品公司主要提供非治疗用的生物产品。 其他则为第三方公司提供生产服务。
Industry: | Biopharmaceuticals |
C/ Jesús y María, 6
BARCELONA
BARCELONA 08022
ES
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球570,000万多名交易者的一份子,选择利用Capital.com进行交易吧。